Assess Satisfaction of Patients and Physicians With Results of Yaz Plus Treatment for 13 Cycles

Bayer1,500 enrolled

Overview

Local prospective multicenter non-comparative non-interventional observational study. It's planed to assess satisfaction of patients and physicians with results of Yaz Plus treatment for 13 cycles in real practice.

Non-interventional, Yaz Plus, Contraception, Assess satisfaction, Russian Federation.

Study Type

OBSERVATIONAL

Enrollment

1,500

Conditions

Contraception

Interventions

BAY98-7071_EE20/DRSP/L-5-MTHFDRUG

Patients treated by Physicians under approved local prescriptions

Eligibility

Sex: FEMALEMin age: 18 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Female patients ≥ 18 years old * Requiring contraception * Prescribed with Yaz Plus for the first time Exclusion Criteria: * Contraindications for the use of Yaz Plus in accordance with the local product information

Locations (1)

Unnamed facility

Many Locations, Russia

Outcomes

Primary Outcomes

Satisfaction measured with a Likert response scale (from 1 - poor to 5 - excellent)

Time frame: Up to 12 months

Secondary Outcomes

Changes in EVAPIL scale for assessment of tolerability of oral contraceptives.

Time frame: Baseline to 12 months

Number of participants with adverse events as a measure of safety and tolerability

Time frame: Up to 12 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.